Leukoplakia clinical trials at UCSD

1 in progress, 0 open to eligible people

Pembrolizumab in Treating Participants With Leukoplakia
Sorry, not currently recruiting here
This phase II pilot trial studies how well pembrolizumab works in treating leukoplakia. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
La Jolla, California and other locations

Last updated: March 25, 2021